Casdin Capital, LLC Foghorn Therapeutics Inc. Transaction History

Casdin Capital, LLC

  • $1.29 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$10.79 - $22.87 $2.32 Million - $4.92 Million
-215,000 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$8.33 - $15.02 $10,129 - $18,264
-1,216 Reduced 0.56%
215,000 $3 Million
Q4 2020

Feb 16, 2021
BUY
$15.12 - $25.88 $3.27 Million - $5.6 Million
216,216 New
216,216 $4.38 Million

Others Institutions Holding FHTX

# of Institutions
80
Shares Held
33.3M
Call Options Held
8.7K
Put Options Held
2.4K
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $326M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Casdin Capital, LLC Portfolio

Follow Casdin Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email